STAT November 7, 2022
Bob Herman

Medicare punts big moves ahead of midterms

Medicare unleashed an avalanche of payment regulations and rules in the past week, and there was a subtle theme hanging over everything: Don’t rock the boat too much for the industry or for seniors, a crucial voting bloc in this week’s midterm elections.

Most notably, CMS punted, yet again, on whether to make Medicare Advantage audits more aggressive. A decision now won’t be made until February. Medicare Advantage insurers despise the thought of the government clawing back more money through these audits, known as “risk adjustment data validation” or RADV. This regulation has been in the works for four years, but CMS said “additional time continues to be needed to address the complex...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Insurance, Medicare, Medicare Advantage
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
How Many Physicians Have Opted Out of the Medicare Program? - 2
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Share This Article